Eye lymphoma, also referred to as ocular lymphoma or intraocular lymphoma, is a rare form of cancer affecting the lymphatic system within the eye. Emerging from lymphocytes, white blood cells pivotal to the immune system, this condition predominantly manifests in older adults, targeting areas like the retina, vitreous humor, or uvea. Symptoms often include blurred vision, floaters, redness, and light sensitivity. Diagnosis involves a comprehensive eye examination, alongside imaging techniques such as MRI or CT scans, and a biopsy to confirm lymphoma cells. Treatment typically entails targeted chemotherapy directly into the eye through intravitreal injections, radiation therapy, or systemic chemotherapy, depending on disease progression. Timely detection and intervention are critical in managing eye lymphoma effectively and preserving visual function.
Objective: To identify the clinical characteristics and prognosis of patients with primary Ocular Adnexal Lymphoma (OAL) in Southern Thailand. Methods: A retrospective case series in a tertiary-care…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Eye Lymphoma work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Eye Lymphoma research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Eye Lymphoma track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Eye Lymphoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Eye Lymphoma are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Eye Lymphoma track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
